Cagrilintide 10mg

Cagrilintide is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist developed for research applications. This 10 mg formulation represents a potent dosage suitable for laboratory and investigational studies examining metabolic regulation and glucose homeostasis. As a research-grade compound, it maintains pharmaceutical standards for scientific inquiry. Cagrilintide demonstrates potential in exploring mechanisms related to appetite signaling and metabolic function. Intended exclusively for qualified research purposes and in vitro studies, this product supports advancement in endocrinological research and drug development protocols.